Lifecore Biomedical

LFCR · NASDAQ

$6.37−$0.02 (−0.31%)TodayMarket closed ·
Prev close $6.39

About LFCR

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 382 full-time employees. The company manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. The company manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. The company also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.

Employees
382
Headquarters
Chaska, Minnesota
Listed
Feb 15, 1996
Sector
Health Care
Industry
Life Sciences Tools & Services

Leadership

Lifecore Biomedical executives
NameTitleSince
Katrina Houde——
Paul Josephs—2024
Ryan Lake——
Thomas Salus——
Humberto Antunes——
Jason Aryeh——
Paul Johnson——
Christopher Kiper——
Matthew Korenberg——
Nelson Obus——
Joshua Schechter——
Stephanie Diaz—2024

Similar companies

Companies in the same industry as Lifecore Biomedical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.